Consumer Scan

Scan

Consumer Scan

raw scan snapshot — prices as of scan date, not live 35 rows · screens, not recommendations ported fromresearch/classic/scans/2026-04-26-consumer-scan.md

Consumer is a bifurcated wreckage. LULU and NKE are in deep structural downtrends (-58% and -44% from 52-week highs), HIMS is the cultural-thesis standout with +47% in 30 days (but approaching overbought at RSI 68), and CROX + SBUX are the only names printing golden crosses. Last scan was 16 days ago (2026-04-10). Protein Economy thesis (BRBR) was closed in retrospective — no BRBR longs.


Quick Snapshot

Signal Reading
Overall 🟡 Bifurcated — cultural/value plays diverging from legacy consumer brands
Cultural thesis HIMS up +47% 30D (near overbought), CROX golden cross +28% 30D
Risk NKE death cross, LULU -25% 3M — both breaking multi-year support
Safe harbor SBUX golden cross, RSI neutral; DECK quiet outperformer
XLY ETF $113.92, RSI 57 — slight recovery but still -6.6% 3M

Price Table

Stock Price 7D 30D 3M RSI vs SMA200 Status Category
HIMS $30.56 -2.3% +46.6% +0.9% 68 -19.3% 🟠 Near Overbought Cultural thesis
CROX $102.32 -6.2% +27.8% +21.8% 61 +17.1% 🟢 Strong Cultural thesis
SBUX $97.48 +3.3% -0.4% +7.6% 58 +9.8% 🟢 Healthy Turnaround
DECK $108.53 -1.2% +8.5% +7.1% 55 +4.9% 🟢 Healthy Footwear
XLY $113.92 +3.8% +1.7% -6.6% 57 -1.7% 🟡 Neutral ETF
AS $35.84 -1.8% +6.6% -5.4% 54 -0.6% 🟡 Neutral Activewear
CMG $34.21 -5.0% +5.3% -13.9% 48 -11.1% 🟡 Neutral Fast casual
DPZ $367.83 -0.6% +1.5% -10.7% 46 -11.1% 🟡 Neutral Cultural thesis
PYPL $49.57 +4.2% +9.1% -12.6% 65 -18.1% 🟡 Neutral Fintech
CRSR $6.58 +1.7% +14.4% +24.4% 69 -6.2% 🟠 Near Overbought Gaming hardware
LULU $143.80 -12.9% -9.4% -25.4% 34 -21.5% 🔴 Breakdown Cultural thesis
NKE $44.69 -2.5% -15.7% -30.8% 35 -30.3% 🔴 Breakdown Legacy footwear

Tier Analysis

Tier 1 — Cultural Thesis (HIMS, LULU, CMG, DPZ, CROX)

HIMS $30.56 | RSI 68 | +47% 30D The GLP-1 telehealth play is ripping. Still -57% from its 52-week high but 46% SMA50 premium tells you the move has been explosive. The risk: RSI approaching overbought, 30-day move is among the sharpest in the scan. Any GLP-1 regulatory headline could whipsaw. Not chasing here — wait for RSI pullback below 55.

CROX $102.32 | RSI 61 | Golden Cross | +28% 30D CROX is the surprise winner. Golden cross confirmed, +17% above SMA200, and +28% in 30 days with relative calm in RSI (61 is not stretched). Cultural resilience play — foam footwear as anti-status signal. This is the better risk/reward than HIMS at current levels.

CMG $34.21 | RSI 48 | -41% from 52wk high Chipotle is structurally broken — death cross, -11% below SMA200, -34% 1-year. The cultural appeal is intact but valuation compression from peak growth multiples is ongoing. RSI 48 is not oversold enough to be interesting. Watch for RSI < 35 before considering.

DPZ $367.83 | RSI 46 | -26% from 52wk high Domino's holding SMA20 almost exactly ($367 price, $367 SMA20). Death cross, -11% below SMA200. The value meal defensive narrative doesn't compensate for lack of technical setup. Wait.

LULU $143.80 | RSI 34 | -58% from 52wk high Lululemon is a falling knife. -12.9% in one week, -25% in 3 months, -62% over 3 years. Death cross, -21.5% below SMA200. The brand is under pressure from DTC competition and post-pandemic athleisure normalization. RSI approaching 30 but momentum is still negative. Not a buy yet — need RSI < 28 and a stabilization week.

Tier 2 — Stalwarts (SBUX, DECK)

SBUX $97.48 | RSI 58 | Golden Cross Starbucks turnaround is quietly working. Golden cross, +9.8% above SMA200, -7% from 52wk high. Brian Niccol effect. Not cheap but the technical setup is among the cleanest in consumer right now. Hold existing positions.

DECK $108.53 | RSI 55 | Golden Cross Deckers (UGG/HOKA) has been the stealth winner — golden cross, +5% above SMA200, positive across all timeframes. Low drama, consistent execution. Underowned by most.

Tier 3 — Broken (NKE)

NKE $44.69 | RSI 35 | -44% from 52wk high Nike is a generational restructuring story happening in real time. -30% below SMA50, -30% below SMA200, death cross. -62% over 3 years. The China business, DTC pivot cost overruns, and brand dilution are compounding. RSI 35 is approaching oversold but not there yet. At RSI < 28 with insider buying this becomes interesting for a bounce trade only — not a conviction rebuild.


Entry Zones

APPROACHING OVERSOLD (RSI 30-40) — Watch Closely

Stock Current Zone RSI 30D Chg Action Notes
LULU $143.80 <$135 34 -9.4% 🔍 Watch Need RSI <28 + base week. -58% from high. Death cross.
NKE $44.69 <$42 35 -15.7% 🔍 Watch RSI approaching oversold but falling knife. Brand still impaired.

NEAR OVERBOUGHT — Don't Chase

Stock Current RSI 30D Chg Action Notes
HIMS $30.56 68 +46.6% ⚠️ Avoid Extended. Wait for pullback to RSI 50-55 before entry.
CRSR $6.58 69 +14.4% ⚠️ Caution Small cap gaming hardware, thin thesis at these levels.

Action Matrix

Action Stocks Why
🔒 HOLD SBUX, CROX, DECK Golden crosses, clean technicals, intact thesis
🔍 WATCH LULU, NKE Approaching oversold but momentum still negative
🔍 WATCH CMG -41% from high, needs RSI <35 for entry interest
⚠️ AVOID HIMS RSI 68, +47% 30D — do not chase. Wait for pullback.
⚠️ AVOID PYPL Structurally broken 5-year chart, no catalyst thesis
❌ SKIP BRBR Protein Economy thesis CLOSED — no longs

What Changed vs 2026-04-10

Stock Then Now Move Note
HIMS ~$21 est $30.56 +47% 30D Cultural thesis igniting
LULU ~$158 est $143.80 -12.9% 7D Accelerating breakdown
NKE ~$53 est $44.69 -15.7% 30D New multi-year low territory
CROX ~$80 est $102.32 +28% 30D Golden cross, momentum building
SBUX stable $97.48 +3.3% 7D Turnaround on track

Key Discoveries

Discovery Implication
CROX golden cross with +17% SMA200 premium Better cultural thesis risk/reward than HIMS at current RSI
LULU down -12.9% in one week Capitulation approaching but not yet; wait for RSI <28
SBUX/DECK both golden cross Stalwart consumer plays outperforming fallen highflyers

Open Questions

  • HIMS regulatory risk: any FDA GLP-1 compounding ruling could gap it -30%. What's the hedge?
  • NKE: is $40 a support floor or just the next pause before further decline?
  • CMG: any Q1 earnings beat catalyst coming that could shift RSI direction?
10 events

No direct external sources are attached to this read.